PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 97 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $2,000 | 0.0% | 325 | 0.0% | 0.00% | – |
Q2 2020 | $2,000 | +100.0% | 325 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | 0.0% | 325 | 0.0% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 325 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 325 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | -50.0% | 325 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | 0.0% | 325 | -38.1% | 0.00% | – |
Q4 2018 | $2,000 | – | 525 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 2,600,410 | $36,172,000 | 26.83% |
Abingworth LLP | 1,301,413 | $18,103,000 | 18.96% |
Roumell Asset Management, LLC | 290,136 | $4,036,000 | 9.16% |
Monashee Investment Management LLC | 100,000 | $1,391,000 | 2.19% |
BVF INC/IL | 575,000 | $7,998,000 | 1.70% |
Aisling Capital LLC | 482,680 | $6,714,000 | 1.59% |
Opaleye Management Inc. | 146,700 | $2,041,000 | 1.36% |
Broadfin Capital, LLC | 803,332 | $11,174,000 | 1.09% |
GENERAL AMERICAN INVESTORS CO INC | 477,076 | $6,636,000 | 0.69% |
Opus Point Partners Management, LLC | 37,665 | $524,000 | 0.51% |